within Pharmacolibrary.Drugs.G_GenitoUrinarySystemAndSexHormones.G02C_OtherGynecologicals.G02CB01_Bromocriptine;

model Bromocriptine
  extends Pharmacolibrary.Drugs.ATC.G.G02CB01;

  annotation (Documentation(
info       = "<html><body><table><tr><td>Drug:</td><td>G02CB01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>2</td></tr></table><p>Bromocriptine is a dopamine receptor agonist derived from ergot alkaloids. It is used primarily in the treatment of Parkinson's disease, hyperprolactinemia, acromegaly, and type 2 diabetes mellitus. It is an approved medication and is still in clinical use for these indications.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters based on healthy adult volunteers (both sexes), single oral dose administration.</p><h4>References</h4><ol><li><p>Friis, ML, et al., &amp; Hvidberg, EF (1979). Pharmacokinetics of bromocriptine during continuous oral treatment of Parkinson&#x27;s disease. <i>European journal of clinical pharmacology</i> 15(4) 275–280. DOI:<a href=\"https://doi.org/10.1007/BF00618517\">10.1007/BF00618517</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/477712/\">https://pubmed.ncbi.nlm.nih.gov/477712</a></p></li><li><p>Schran, HF, et al., &amp; Bhuta, SI (1985). Pharmacokinetics and pharmacodynamics of bromocriptine in the rat. <i>Biopharmaceutics &amp; drug disposition</i> 6(3) 301–311. DOI:<a href=\"https://doi.org/10.1002/bdd.2510060305\">10.1002/bdd.2510060305</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/4041556/\">https://pubmed.ncbi.nlm.nih.gov/4041556</a></p></li><li><p>Rabey, JM, et al., &amp; Graff, E (1989). The influence of levodopa in the pharmacokinetics of bromocriptine in Parkinson&#x27;s disease. <i>Clinical neuropharmacology</i> 12(5) 440–447. DOI:<a href=\"https://doi.org/10.1097/00002826-198910000-00009\">10.1097/00002826-198910000-00009</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2611767/\">https://pubmed.ncbi.nlm.nih.gov/2611767</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
end Bromocriptine;
